PMID: 7011469Dec 1, 1980Paper

Controlled trial of sulpiride in chronic schizophrenic patients

The British Journal of Psychiatry : the Journal of Mental Science
J G EdwardsT Zutchi

Abstract

In a double-blind comparative trial of sulpiride (600-1,800 mg/day) and trifluoperazine (15-45 mg/day) in 38 chronic schizophrenic patients, ratings of therapeutic results and unwanted effects were made at two-weekly interviews during the six weeks treatment period. The results show that sulpiride has neuroleptic properties and a spectrum of therapeutic activity similar to that of trifluoperazine. There was an association between plasma sulpiride levels and therapeutic response after four weeks' treatment.

References

Aug 6, 1979·Life Sciences·P Jenner, C D Marsden
Aug 8, 1979·Psychopharmacology·L BjerkenstedtG Sedval
Jun 2, 1975·Calcified Tissue Research·A E Shamoo, F Bronner
Jan 11, 1979·Nature·J W Kebabian, D B Calne
Jul 1, 1979·Acta Psychiatrica Scandinavica·O Bratfos, J O Haug
May 1, 1977·Neuropharmacology·P N ElliottR Miller
Jan 1, 1978·The Journal of Nervous and Mental Disease·B S Dohrenwend, B P Dohrenwend
Aug 1, 1975·Agents and Actions·D C Atkinson, R Hicks
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Mar 1, 1970·The British Journal of Psychiatry : the Journal of Mental Science·J L Birley, G W Brown
Sep 1, 1968·Journal of Health and Social Behavior·G W Brown, J L Birley

❮ Previous
Next ❯

Citations

Feb 1, 1984·Neuropharmacology·G N WoodruffJ A Poat
Mar 1, 1993·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H J Möller
Feb 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A MucciM Maj
Jan 1, 1997·European Psychiatry : the Journal of the Association of European Psychiatrists·R ShilohA Weizman
Aug 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·N Quinn, C D Marsden
Sep 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·J G Edwards, M Glen-Bott
Jul 1, 1989·Acta Psychiatrica Scandinavica·U LepolaA Gordin
Jan 1, 1984·Acta Psychiatrica Scandinavica. Supplementum·E Munk-AndersenJ Gerlach
Jan 1, 1984·Acta Psychiatrica Scandinavica. Supplementum·C HärnrydA Aberg-Wistedt
Jan 1, 1983·British Journal of Clinical Pharmacology·J G Edwards, A Goldie
Jan 1, 1983·British Journal of Clinical Pharmacology·J G Edwards, M Glen-Bott
May 5, 2000·The Cochrane Database of Systematic Reviews·B G SoaresP Chue
Apr 15, 2014·The Cochrane Database of Systematic Reviews·Jijun Wang, Stephanie Sampson
Nov 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·C HallstromM Lader
Feb 20, 2004·The Cochrane Database of Systematic Reviews·L O MarquesB G O Soares
Sep 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·J GerlachH Nielsen
Oct 1, 1996·The Australian and New Zealand Journal of Psychiatry·A Sarfraz, M Cook
Mar 1, 1983·The Journal of Pharmacy and Pharmacology·L M ReynoldsC D Marsden
Feb 1, 1995·The Annals of Pharmacotherapy·C F Caley, S S Weber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here